DAVID ALBERTS, MD
Osteopathic Medicine at Campbell Ave, Tucson, AZ
License number
Arizona 8993
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1515 N Campbell Ave, Tucson, AZ 85724
Phone
(520) 874-3500
(520) 874-3484 (Fax)
(520) 874-4135
(520) 874-7048 (Fax)
(520) 874-3484 (Fax)
(520) 874-4135
(520) 874-7048 (Fax)
Organization information
See more information about DAVID ALBERTS at bizstanding.comDavid Alberts MD
3838 N Campbell Ave, Tucson, AZ 85719
Industry:
Internist
Phone:
(520) 694-2873 (Phone)
David Saml Alberts
Professional information
David S Alberts, Tucson AZ
Specialties:
Oncologist
Address:
1515 N Campbell Ave, Tucson, AZ 85724
Education:
University of Virginia, School of Medicine - Doctor of Medicine
UCSF Medical Center - Fellowship - Clinical Pharmacology
National Institutes of Health-Clinical Center - Residency - Oncology (Internal Medicine)
UCSF Medical Center - Fellowship - Clinical Pharmacology
National Institutes of Health-Clinical Center - Residency - Oncology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
David Samuel Alberts, Tucson AZ
Specialties:
Hematology & Oncology, Medical Oncology, Gynecology, Public Health & General Preventive Medicine
Work:
Arizona Cancer Ctr
1515 N Campbell Ave, Tucson, AZ 85724 University Medical Center - Tucson
1501 N Campbell Ave, Tucson, AZ 85724
1515 N Campbell Ave, Tucson, AZ 85724 University Medical Center - Tucson
1501 N Campbell Ave, Tucson, AZ 85724
Education:
University of Virginia (1966)
Methods For The Treatment Of Nephro-Disorders Using Aminothiol Compounds
US Patent:
6586476, Jul 1, 2003
Filed:
Oct 28, 1999
Appl. No.:
09/429290
Inventors:
Martin Stogniew - Blue Bell PA
David S. Alberts - Tucson AZ
Edward H. Kaplan - Skokie IL
David S. Alberts - Tucson AZ
Edward H. Kaplan - Skokie IL
Assignee:
MedImmune Oncology, Inc. - Gaithersburg MD
International Classification:
A61K 3166
US Classification:
514665, 514114, 514649, 514608, 514706
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Instrument For Measuring Tumors
US Patent:
D310044, Aug 21, 1990
Filed:
Apr 9, 1987
Appl. No.:
7/036245
Inventors:
David S. Alberts - Tucson AZ
Robert T. Dorr - Tucson AZ
Robert T. Dorr - Tucson AZ
US Classification:
D10 73
Self-Sheathing Hypodermic Needle
US Patent:
4906236, Mar 6, 1990
Filed:
Aug 29, 1988
Appl. No.:
7/237729
Inventors:
David S. Alberts - Tucson AZ
Robert T. Dorr - Tucson AZ
Robert T. Dorr - Tucson AZ
International Classification:
A61M 532
US Classification:
604198
Abstract:
A needle assembly comprises a needle having a sharp point encased within and movable with respect to a sheath having a blunt end. A hub attached to the sheath has a recess therein for receiving a compressible member carried by an end of the needle having a collar thereon for engaging the compressible member. The compressible member retracts the point of the needle into the interior of the sheath to prevent contact of the point by user of the needle. When the needle assembly is attached to a syringe, or other instrument, the collar of the needle is engaged by a portion of the syringe and moved to compress the compressible member and expose the point of the needle for use.
Method For Deactivating A Contaminant
US Patent:
5985302, Nov 16, 1999
Filed:
Jul 10, 1998
Appl. No.:
9/113734
Inventors:
Robert T. Dorr - Tucson AZ
David S. Alberts - Tucson AZ
David S. Alberts - Tucson AZ
Assignee:
Supergen, Inc. - San Ramon CA
International Classification:
A01N 2534, A01N 2500, D06L 300
US Classification:
424404
Abstract:
Methods, compositions and a kit for deactivating spills or leaks of HIV infected blood or anticancer drugs by applying to the leak or spill an aqueous solution containing calcium hypochlorite or sodium hypochlorite as the active ingredient. In order to thicken the aqueous solution and thus keep it from spreading beyond its intended area of application, the solution of calcium hypochlorite contains methylcellulose. In addition to chemically deactivating the active anticancer drug, the solution of the invention also effectively decolorizes it, thus preventing permanent stains on any surface or fabric with which the anticancer drug comes into contact.
Methods For The Treatment Of Neuro- Disorders Using Aminothiol Compounds
US Patent:
7105575, Sep 12, 2006
Filed:
May 3, 2002
Appl. No.:
10/137686
Inventors:
Martin Stogniew - Blue Bell PA, US
David S. Alberts - Tucson AZ, US
Edward H. Kaplan - Skokie IL, US
David S. Alberts - Tucson AZ, US
Edward H. Kaplan - Skokie IL, US
Assignee:
Medimmune Oncology Inc. - Gaithersburg MD
International Classification:
A16K 31/13, A16K 31/66, A16K 31/135, A16K 31/16, A16K 31/095
US Classification:
514665, 514114, 514649, 514608, 514706
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Methods For Treatment Of Neuro- And Nephro- Disorders And Therapeutic Toxicities Using Aminothiol Compounds
US Patent:
2006027, Nov 30, 2006
Filed:
Aug 9, 2006
Appl. No.:
11/501949
Inventors:
Martin Stogniew - Blue Bell PA, US
David Alberts - Tucson AZ, US
Edward Kaplan - Skokie IL, US
David Alberts - Tucson AZ, US
Edward Kaplan - Skokie IL, US
International Classification:
A61K 31/66, A61K 31/13
US Classification:
514114000, 514665000
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Methods Of Use Related To Xerostomia
US Patent:
2011016, Jul 7, 2011
Filed:
Dec 8, 2010
Appl. No.:
12/963574
Inventors:
Martin STOGNIEW - Blue Bell PA, US
David S. ALBERTS - Tucson AZ, US
Edward H. KAPLAN - Skokie IL, US
David S. ALBERTS - Tucson AZ, US
Edward H. KAPLAN - Skokie IL, US
International Classification:
A61K 31/661, A61P 35/00
US Classification:
514114
Abstract:
The present invention relates to new uses of thermally stable, crystalline S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by radiation treatment. In particular, the invention provides a method for treating or preventing xerostomia associated with the administration of radiation treatment of head and neck cancer.
Topical Dmso Treatment For Palmar-Plantar Erythrodysethesia
US Patent:
6060083, May 9, 2000
Filed:
Apr 1, 1999
Appl. No.:
9/283208
Inventors:
Robert T. Dorr - Tucson AZ
David S. Alberts - Tucson AZ
David S. Alberts - Tucson AZ
Assignee:
Topical Technologies, Inc. - Tuscon AZ
International Classification:
A61K 3110, A61K 9127
US Classification:
424450
Abstract:
A method for treating palmar-plantar erythrodysethesia syndrome includes applying to affected areas a therapeutically effective amount of a dimethyl sulfoxide solution.